Yahoo
XETRA - Delayed Quote EUR

MEDICLIN Aktiengesellschaft (MED.DE)

5.30 -0.05 (-0.93%)
At close: October 30 at 5:35:24 PM GMT+1
Chart Range Bar
Loading chart for MED.DE
  • Previous Close 5.35
  • Open 5.25
  • Bid --
  • Ask --
  • Day's Range 5.25 - 5.30
  • 52 Week Range 3.22 - 5.80
  • Volume 1,822
  • Avg. Volume 7,959
  • Market Cap (intraday) 251.75M
  • Beta (5Y Monthly) 0.49
  • PE Ratio (TTM) 8.55
  • EPS (TTM) 0.62
  • Earnings Date --
  • Forward Dividend & Yield 0.04 (0.75%)
  • Ex-Dividend Date May 29, 2026
  • 1y Target Est 7.30

MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute; Acute; and Nursing Care and Service segments. It offers medical services in the areas of neurology; psychosomatics; orthopedics; internal medicine; cardiology; oncology; geriatrics; psychiatry; otorhinolaryngology; cardiac medicine; rheumatology; gynecology; trauma, heart, and general surgeries; urology; and others. The company also provides services in the areas of ENT and acute outpatient services. It owns 31 clinical facilities, rehabilitation care, 6 nursing care facilities, and 9 medical care centers in 11 German federal states. The company was incorporated in 1994 and is headquartered in Offenburg, Germany.

www.mediclin.de

7,048

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

MED.DE
44.78%
DAX P (^GDAXI)
5.42%

1-Year Return

MED.DE
44.78%
DAX P (^GDAXI)
7.05%

3-Year Return

MED.DE
104.14%
DAX P (^GDAXI)
75.44%

5-Year Return

MED.DE
32.44%
DAX P (^GDAXI)
64.56%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY11
Revenue 125.9M
Earnings --
Profit Margin 0.00%

Q4

FY10

Q2

FY11

Q3

FY11

Q4

FY11

0
20M
40M
60M
80M
100M
120M
0.0%
1.0%
2.0%
3.0%

Analyst Insights

View More

Analyst Price Targets

7.30
7.30 Average
5.30 Current
7.30 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.55%

  • Return on Assets (ttm)

    4.61%

  • Return on Equity (ttm)

    11.93%

  • Revenue (ttm)

    819.84M

  • Net Income Avi to Common (ttm)

    29.11M

  • Diluted EPS (ttm)

    0.62

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    77.39M

  • Total Debt/Equity (mrq)

    146.92%

  • Levered Free Cash Flow (ttm)

    17.74M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: